Vjecha, MJ;
Tiberi, S;
Zumla, A;
(2018)
Accelerating the development of therapeutic strategies for drug-resistant tuberculosis.
[Editorial comment].
Nature Reviews Drug Discovery
, 17
(9)
pp. 607-608.
10.1038/nrd.2018.28.
Preview |
Text
Zumla_Accepted version NRDD comment rev 16-feb-18.pdf - Accepted Version Download (854kB) | Preview |
Abstract
Recent progress in the discovery, development and evaluation of new drugs and combination regimens for drug-resistant tuberculosis through greater collaboration between industry, donors and academia provides renewed hope for overcoming the challenges in tuberculosis treatment.
| Type: | Article |
|---|---|
| Title: | Accelerating the development of therapeutic strategies for drug-resistant tuberculosis |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/nrd.2018.28 |
| Publisher version: | https://doi.org/10.1038/nrd.2018.28 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | drug-resistant TB, new drugs, development, treatment regimens, pipeline |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10057202 |
Archive Staff Only
 |
View Item |
